-inc-logo-1200x675.png){kind=logo}
Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF – Get Free Report)’s stock price rose 2.8% during mid-day trading on Tuesday . The stock traded as high as $12.76 and last traded at $12.56. Approximately 2,337,302 shares traded hands during mid-day trading, a decline of 31% from the average daily volume of 3,376,665 shares. The stock had previously closed at $12.22.
Mind Medicine (MindMed) Stock Performance
The company has a 50 day moving average of $9.85 and a two-hundred day moving average of $7.94.
Mind Medicine (MindMed) Company Profile
Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
Featured Stories
- Five stocks we like better than Mind Medicine (MindMed)
- What is the Shanghai Stock Exchange Composite Index?
- EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming Sector
- What is Short Interest? How to Use It
- These Are the 3 Hottest Sectors for Q3 Earnings Growth
- 3 Fintech Stocks With Good 2021 Prospects
- AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.
